They also dive into past hurdles in the space and highlight the varied approaches— including their own— that a new generation ...

KateTx debuted less than a year ago with a $51 million Series A round co-led by Westlake Village BioPartners and Versant ...

May 09, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq ... as well as its enzymatic synthesis manufacturing at the American Society of Gene and Cell Therapy (ASGCT) 27 th Annual Meeting. A sixth ...

After four years of advocacy and supporting first-generation students, University of Iowa Undergraduate Student Government President Mitch Winterlin is taking his skills to K-12 classrooms following ...

Expanded payload capacity of Anellovectors widens the therapeutic potential of this novel class of viral vectorsData showcasing transduction and ...

Double major Grace Johnson will cross the stage this month — twice. She will cross once as a student in the UTSA College for Health Community and Policy for her degree in psychology, and again for her ...

With its $525 million investment, Royalty Pharma will acquire the royalties and milestones for ImmuNext’s anti-CD40 therapy ...

N ovo Nordisk has entered a research partnership with Flagship Pioneering and Metaphore Biotechnologies in a joint effort to ...

OverT Bio, a data-driven company working to unlock the curative potential of cell therapies in solid tumors, announced today that it has raised $16 million in seed funding. The round was co-led by ...

The American Psychiatric Association urges “ethical practitioners” to “refrain from attempts to change individuals’ sexual ...

Crenolanib may have advantages over other therapies targeting acute myeloid leukemia with FLT3 gene mutations.

In a trial, SMA gene therapy EXG001-307 helped a small group of young children with type 1 better control their heads and sit ...